EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nuclear medicine in hematology: Bridging diagnostics and therapy

Julius Jungnitsch iD, Kirsten Korsholm, Fazila Asmar, Søren Møller

Clinical Physiology and Functional Imaging · 2025

DOI: 10.1111/cpf.70031 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Physiology and Functional Imaging, 2025. Verfasst von Julius Jungnitsch und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Physiology and Nuclear Medicine, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvi…. Hauptthemen laut MEDLINE: Nuclear Medicine, Radiopharmaceuticals, Hematologic Diseases, Hematology. Die Arbeit nennt 179 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The investigation and therapeutic trials of hematological and hemato‐oncological diseases using nuclear medicine methods dates back to the 1930s. At that time, 32 P was used as the isotope for various experimental procedures. Over the years, a wide variety of isotopes and techniques have been developed, some of which have established themselves as the gold standard in certain clinical indications, such as in the management of patients with lymphoma. Other nuclear medicine procedures are used as complementary techniques in more specific clinical scenarios. In recent years, the concept of theranostics has gained popularity in nuclear medicine. Radioendotherapies have been developed and some of them have already been FDA approved. Their promising results could potentially have a major impact on the treatment of patients with hemato‐oncologic diseases. In this article we review some of the contemporary techniques used in nuclear medicine and recent developments of clinical indications in the field of hematology and oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear MedicineRadiopharmaceuticalsHematologic DiseasesHematologyHematologic NeoplasmsHumansPredictive Value of TestsTreatment Outcome

Stichwörter der Autor:innen

AMLImmuno PETPETfunctional diagnosticsfunctional imaginghematologyisotope therapylymphomamultiple myelomanuclear medicineradio ligand therapyradiomediated therapyscintigraphytheranostic

Substanzen

Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Clinical Physiology and Nuclear Medicine, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
  • Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Julius Jungnitsch

Zitieren

APA

Jungnitsch, J., Korsholm, K., Asmar, F., & Møller, S. (2025). Nuclear medicine in hematology: Bridging diagnostics and therapy. Clinical Physiology and Functional Imaging. https://doi.org/10.1111/cpf.70031

Vancouver

Jungnitsch J, Korsholm K, Asmar F, Møller S. Nuclear medicine in hematology: Bridging diagnostics and therapy. Clinical Physiology and Functional Imaging. 2025. doi:10.1111/cpf.70031

BibTeX
@article{Jungnitsch2025,
  author = {Jungnitsch, Julius and Korsholm, Kirsten and Asmar, Fazila and Møller, Søren},
  title = {Nuclear medicine in hematology: Bridging diagnostics and therapy},
  journal = {Clinical Physiology and Functional Imaging},
  year = {2025},
  doi = {10.1111/cpf.70031}
}
Kostenlos starten →